2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow SOR-C13: new trials by email Literature Review of SOR-C13 trials Research Report on SOR-C13
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors TRPV6 Calcium Channel Inhibitor SOR-C13 - Advanced Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm | Phase 1 | Completed | M.D. Anderson Cancer Center | 11 | 2019-07-29 | 2023-11-18 |
| Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel SOR-C13 - Cancer | Phase 1 | Completed | Soricimed Biopharma Inc | 23 | 2012-07-01 | 2016-06-23 |
Ovarian Neoplasms (2) · Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1)
M.D. Anderson Cancer Center (1) · Soricimed Biopharma Inc (1)
United States (2) · Canada (1)
Siqing Fu (1) · Toney T Ilenchuk, MS, PhD (1)